四川医学2011，Vol.32Issue(6)：899-900,2.
巴曲酶联合依达拉奉治疗进展型脑梗死44例临床疗效分析
United batroxobin edaravone treatment of progressive clinical analysis of 44 cases of cerebral infarction
周启才 1林泽鹏2
作者信息
- 1. 深圳市宝安区松岗人民医院药剂科,广东,深圳,518105
- 2. 深圳市孙逸仙心血管医院心内科,广东,深圳,518020
- 折叠
摘要
Abstract
Objective To observe the Batroxobin progress in the United edaravone treatment of cerebral infarction. Methods 88 patients with onset of the progress of 6 ～ 72h cerebral infarction were randomly divided into two groups and the controlgroup 44 patients in hoth groups were given conventional treatment , while the ohservation group Batroxobin United edaravone treatment group plus batroxobin treatment,after treatment were compared the efficacy and adverse effects. Results The total effective rate of the observation group 93. 18％ , total effective rate of the control group 79. 55％ , ×2 calculated by the two groups , the difference was significant ( P ＜ 0. 05 ) . Two groups of neurological function after treatment were lower than hefore treatment assessment.and the observation group were significantly lower than the control group , the statistical analysis showed significant difference( P ＜ 0. 05 ) . Observation group no significant adverse reactions. Conclusion Batroxobin United edaravone treatment of progressive cerebral infarction was no obvious side effects,safe , reliable , should be widely applied.关键词
巴曲酶/依达拉奉/进展型脑梗死Key words
batroxobin / edaravone / progressive cerebral infarction分类
医药卫生引用本文复制引用
周启才,林泽鹏..巴曲酶联合依达拉奉治疗进展型脑梗死44例临床疗效分析[J].四川医学,2011,32(6):899-900,2.
